Vaccinex (VCNX) Misses Q3 EPS by 83c

Vaccinex (NASDAQ: VCNX) reported Q3 EPS of ($1.09), $0.83 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $20 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Vaccinex (VCNX) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Mammoth Energy Services (TUSK) Reports Q2 Loss of $0.01
• Alta Mesa Resources (AMR) Misses Q2 EPS by 128c